ISSN: 2423-6438  
J Renal Endocrinol. 2015;1(1): e7.

Hypothesis

Hypomagnesemia and cisplatin nephrotoxicity

Hamid Nasri *

1 Nickan Research Institute, Isfahan, Iran.
*Corresponding author: Professor Hamid Nasri, Email: hamidnasri@med.mui.ac.ir

Please cite this paper as: Nasri H. Hypomagnesemia and cisplatin nephrotoxicity. J Renal Endocrinol. 2015;1:e07.

Implication for health policy/practice/research/medical education

Hypomagnesemia develops after cisplatin therapy and magnesium therapy is suggested to patients to prevent the hypomagnesemia after cisplatin therapy. Supplementation of magnesium may promote kidney toxicity of cisplatin, and therefore further studies are required to determine the exact role of magnesium in cisplatin metabolism.

First name
 
Last name
 
Email address
 
Comments
 
Security code


Submitted: 12 Apr 2015

Accepted: 13 May 2015
First published online: 07 Jun 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract Page Views: 116
PDF Downloads: 207
Full Text Views: 0